Send me real-time posts from this site at my email
Quantcha

StockTwits Trending Alert: Trading recent interest in CELLDEX THERAPEUTICS

Quantcha now offering unlimited commission-free options trading.

Quantchabot has detected a promising Short Risk Reversal trade opportunity for CELLDEX THERAPEUTICS (CLDX) for the 17-Sep-2021 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.

CLDX was recently trading at $43.72 and has an implied volatility of 75.65% for this period. Based on an analysis of the options available for CLDX expiring on 17-Sep-2021, there is a 34.12% likelihood that the underlying will close within the analyzed range of $34.74-$43.72 at expiration. In this scenario, the average linear return for the trade would be 44.77%.

Trending on StockTwits: StockTwits® is a financial communications platform for the financial and investing community. On their site, CELLDEX THERAPEUTICS was recently trending, indicating that breaking news and/or market activity has significantly impacted sentiment toward the stock. This movement can be interpretted as a sign of more near-term price movement for the underlying.

Trade approach: The recent sentiment change in CLDX on StockTwits appears to be moderately negative, indicating that the stock is likely to follow in that direction for investors trading on sentiment. As a result, a bearish strategy could prove effective if the sentiment ultimately turns out to drive trading.

Upside potential: Using this bearish strategy, the trade would be profitable if CELLDEX THERAPEUTICS closed at or below $43.90 on 17-Sep-2021. Based on our analysis, there is a 50.70% likelihood of this return.

Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment.

To analyze this trade in depth, please visit the Quantcha Options Search Engine.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue